Brian M. Stolz
2015
In 2015, Brian M. Stolz earned a total compensation of $9.2M as Senior Vice President and General Manager at Valeant Pharmaceuticals International, a 694% increase compared to previous year.
Compensation breakdown
| Bonus | $50,000 |
|---|---|
| Non-Equity Incentive Plan | $594,217 |
| Salary | $538,514 |
| Stock Awards | $8,022,062 |
| Other | $15,927 |
| Total | $9,220,720 |
Stolz received $8M in stock awards, accounting for 87% of the total pay in 2015.
Stolz also received $50K in bonus, $594.2K in non-equity incentive plan, $538.5K in salary and $15.9K in other compensation.
Rankings
In 2015, Brian M. Stolz's compensation ranked 602nd out of 13,638 executives tracked by ExecPay. In other words, Stolz earned more than 95.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 602 out of 13,638 | 96th |
Division Manufacturing | 211 out of 5,190 | 96th |
Major group Chemicals And Allied Products | 77 out of 1,854 | 96th |
Industry group Drugs | 58 out of 1,528 | 96th |
Industry Pharmaceutical Preparations | 46 out of 1,182 | 96th |
Source: SEC filing on April 29, 2016.
Stolz's colleagues
We found six more compensation records of executives who worked with Brian M. Stolz at Valeant Pharmaceuticals International in 2015.
2015
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2015
Robert Rosiello
Valeant Pharmaceuticals International
Chief Financial Officer
2015
Anne Whitaker
Valeant Pharmaceuticals International
Group Chairman
2015
Debora Jorn
Valeant Pharmaceuticals International
Group Chairman
2015
Ari Kellen
Valeant Pharmaceuticals International
Group Chairman
2015
Howard Schiller
Valeant Pharmaceuticals International